# MicroPort Orthopedics Inc. clinical trials: 26 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 26 trials with MicroPort Orthopedics Inc. as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by MicroPort Orthopedics Inc.: 26 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/microport-orthopedics-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 6, 2026 | NCT07391592 | Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert | MicroPort Orthopedics Inc. | Observational | Active not recruiting | Osteoarthitis, Arthritis Knee, Joint Diseases, Avascular Necrosis, Rheumatoid Arthritis of Knee | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07391592) |
| November 21, 2023 | NCT06142669 | EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up Study Protocol | MicroPort Orthopedics Inc. | Observational | Recruiting | Joint Diseases | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06142669) |
| March 25, 2021 | NCT04816773 | Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert | MicroPort Orthopedics Inc. | Observational | Enrolling by invitation | Joint Diseases, Osteoarthritis, Arthritis Knee, Avascular Necrosis | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04816773) |
| November 4, 2020 | NCT04615039 | Post Market Clinical Follow-Up Study for MicroPort PROFEMUR® Preserve Classic Femoral Stem | MicroPort Orthopedics Inc. | Observational | Withdrawn | Joint Diseases | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04615039) |
| March 10, 2020 | NCT04301622 | Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur | MicroPort Orthopedics Inc. | Observational | Active not recruiting | Knee Osteoarthritis, Traumatic Arthritis of Knee, Avascular Necrosis, Degenerative Joint Disease of Knee, Rheumatoid... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04301622) |
| November 1, 2019 | NCT04147559 | Post Market Clinical Follow-Up Study for PROFEMUR® Preserve Classic Femoral Stem | MicroPort Orthopedics Inc. | Observational | Enrolling by invitation | Joint Diseases | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04147559) |
| October 30, 2019 | NCT04145401 | Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK | MicroPort Orthopedics Inc. | Observational | Enrolling by invitation | Knee Osteoarthritis | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04145401) |
| August 21, 2019 | NCT04064008 | Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Z Revision Femoral Stems | MicroPort Orthopedics Inc. | Observational | Enrolling by invitation | Joint Disease | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04064008) |
| March 7, 2019 | NCT03865667 | Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Preserve Femoral Stem | MicroPort Orthopedics Inc. | Observational | Active not recruiting | Joint Disease | 63 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03865667) |
| July 3, 2018 | NCT03576573 | Post Market Clinical Follow-Up Study Protocol for PROCOTYL® C Acetabular Components | MicroPort Orthopedics Inc. | Observational | Enrolling by invitation | Joint Disease | 143 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03576573) |
| March 1, 2018 | NCT03450733 | Wright Medical Technology Metal-on-Metal 522 Post-Market Surveillance Study | MicroPort Orthopedics Inc. | Observational | Completed | Osteoarthritis, Hip, Hip Disease, Hip Osteoarthritis, Joint Pain | 173 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03450733) |
| August 12, 2016 | NCT02865447 | Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis | MicroPort Orthopedics Inc. | Observational | Completed | Joint Disease | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02865447) |
| July 6, 2016 | NCT02823834 | PMCF Study Protocol for PROFEMUR® Gladiator Plasma Femoral Stems and PROCOTYL® L Beaded Acetabular Components | MicroPort Orthopedics Inc. | Observational | Active not recruiting | Joint Disease | 121 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02823834) |
| January 29, 2016 | NCT02668211 | Radiostereometric Analysis (RSA) of the PROFEMUR® Preserve Classic Femoral Components | MicroPort Orthopedics Inc. | Not applicable | Withdrawn | Joint Disease, Osteoarthritis | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02668211) |
| October 28, 2015 | NCT02589197 | Gait and Functional Outcomes Study Following Total Knee Arthroplasty With Medial-pivot or Posterior-stabilized Implants | MicroPort Orthopedics Inc. | Observational | Completed | Joint Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02589197) |
| July 23, 2015 | NCT02507258 | PMCF Study for PROFEMUR® Am Femoral Components and PROCOTYL® O HA Coated Acetabular Components | MicroPort Orthopedics Inc. | Observational | Withdrawn | Joint Disease | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02507258) |
| March 25, 2015 | NCT02397746 | Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator Cemented Femoral Stems | MicroPort Orthopedics Inc. | Observational | Terminated | Joint Disease | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02397746) |
| January 30, 2015 | NCT02351414 | Post Market Follow-Up Study of the EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts | MicroPort Orthopedics Inc. | Observational | Active not recruiting | Joint Disease | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02351414) |
| December 11, 2014 | NCT02314702 | Post Market Clinical Follow-Up Study Protocol for PROFEMUR® L Revision Femoral Stems | MicroPort Orthopedics Inc. | Observational | Active not recruiting | Joint Disease | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02314702) |
| December 11, 2014 | NCT02314611 | Post Market Clinical Follow-Up Study Protocol for PROFEMUR® Gladiator HA Coated Modular Femoral Stems | MicroPort Orthopedics Inc. | Observational | Terminated | Joint Disease | 154 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02314611) |
| December 5, 2014 | NCT02309593 | Post Market Clinical Follow-up Study Protocol for PROFEMUR® Xm Femoral Stems | MicroPort Orthopedics Inc. | Observational | Terminated | Joint Disease | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02309593) |
| November 7, 2014 | NCT02285842 | Post Market Clinical Follow-Up Study Protocol for CONSERVE® Press-Fit Femoral Components | MicroPort Orthopedics Inc. | Observational | Active not recruiting | Joint Disease | 143 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02285842) |
| September 15, 2014 | NCT02239783 | Post Market Clinical Follow-Up Study Protocol for PROFEMUR® TL Modular Femoral Stems | MicroPort Orthopedics Inc. | Observational | Active not recruiting | Joint Disease | 143 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02239783) |
| May 29, 2014 | NCT02149667 | Post Market Clinical Follow-up Study Protocol for DYNASTY® BioFoam® Acetabular Components | MicroPort Orthopedics Inc. | Observational | Active not recruiting | Joint Disease | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02149667) |
| June 7, 2011 | NCT01367899 | CONSERVE Plus Post-Approval Study (PAS) | MicroPort Orthopedics Inc. | Observational | Terminated | Other and Unspecified Injury to Hip and Thigh | 199 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01367899) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 4 | 1 |
| Not applicable | 1 |
| Observational | 24 |

## By status

| Status | Trials |
| --- | --- |
| Active not recruiting | 9 |
| Enrolling by invitation | 5 |
| Terminated | 5 |
| Completed | 3 |
| Withdrawn | 3 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Joint Diseases | 21 |
| Osteoarthritis | 17 |
| Osteonecrosis | 15 |
| Ankylosis | 12 |
| Arthritis, Rheumatoid | 12 |
| Musculoskeletal Diseases | 3 |
| Osteoarthritis, Knee | 3 |
| Osteoarthritis, Hip | 1 |
| Arthralgia | 1 |
| Arthritis | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Commercial refrigeration companies in the United States](https://specstream.ai/data/businesses/commercial-refrigeration-companies/united-states)
- [Natural gas utilities in the United States](https://specstream.ai/data/businesses/natural-gas-utilities/united-states)
- [Appliance manufacturers in the United States](https://specstream.ai/data/businesses/appliance-manufacturers/united-states)
- [Guatemalan restaurants in the United States](https://specstream.ai/data/businesses/guatemalan-restaurants/united-states)
- [Smoothie and juice bars in the United States](https://specstream.ai/data/businesses/smoothie-and-juice-bars/united-states)
- [Construction management firms in the United States](https://specstream.ai/data/businesses/construction-management-firms/united-states)
